Show simple item record

dc.contributor.authorNijhuis, Haye
dc.contributor.authorCaniels, Tom
dc.contributor.authorCoughlan, Lynda
dc.date.accessioned2022-06-13T15:40:27Z
dc.date.available2022-06-13T15:40:27Z
dc.date.issued2022-06-07
dc.identifier.urihttp://hdl.handle.net/10713/19137
dc.descriptionPoster presented at a local BioPark meeting, June 7, 2022en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshRespiratory Syncytial Virus Vaccinesen_US
dc.subject.meshImmunizationen_US
dc.subject.meshExosomesen_US
dc.subject.meshMiceen_US
dc.titleMaximizing the immunogenicity of adenoviral (Ad)-based vaccines encoding stabilized RSV pre-fusion Fen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2022-06-13T15:40:28Z


Files in this item

Thumbnail
Name:
SOM_Nijhuis_2022.pdf
Size:
1.535Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International